Comparative Effectiveness of Different Techniques for Repeat Ablation of Atrial Fibrillation
Part of paid clinical trials in Rochester, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT06988202
- Status
- Enrolling By Invitation
Conditions
- Atrial Fibrillation (AF)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Pulmonary Vein Isolation (PVI) without Left Atrial Posterior Wall Isolation (PWI) — PROCEDUREA doctor inserts a thin, flexible tube (called a catheter) through a blood vessel, usually in the groin, and guides it to the heart. Once the catheter is in place, the doctor uses pulsed field electroporation, heat (radiofrequency) or cold (cryoablation) to create small scars in the area where the pulmonary veins connect to the left atrium of the heart. These scars block the faulty electrical signals that cause AF, helping the heart maintain a normal rhythm.
- Pulmonary Vein Isolation (PVI) with Left Atrial Posterior Wall Isolation (PWI) — PROCEDUREPVI with an additional step where the doctor also isolates the back wall (posterior wall) of the left atrium.
Study Details
Atrial fibrillation (AF) is the most common type of irregular heartbeat doctors see. People with AF sometimes have a procedure called an ablation to help get their heart back into a normal rhythm. However, this treatment doesn't always work. This study is looking at whether adding an extra step to the usual ablation-specifically treating another area of the heart called the left atrial (LA) posterior wall-can help people feel better overall, compared to just repeating the standard pulmonary vein isolation ablation procedure.
Key Dates
- Start date
- Mar 18, 2026
- Status verified
- Mar 2026
- Primary completion
- Jan 1, 2030
- Completion
- Dec 31, 2031
Study Design
- Enrollment
- 630 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Other: Repeat PVI without LA PWI
- Other: Repeat PVI with LA PWI
Primary Outcome Measure
Mean Change of Symptom Score on the Atrial Fibrillation Severity Scale (AFSS) [ Time Frame: From Baseline to Month 12 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Rochester Clinical Cardiovascular Research Center | Rochester | New York | 14642 | - |
Find similar trials in Rochester, NY
Related Studies
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)PHASE3 · Recruiting · Anthos Therapeutics, Inc. · Birmingham, Alabama
- Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)Recruiting · McMaster University · Evanston, Illinois
- Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF StudyRecruiting · Vektor Medical · Jonesboro, Arkansas
- Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive ProcedureRecruiting · McMaster University · Hartford, Connecticut